Health Canada drug identification number

DIN 02550423 — CABTREO 0.15 %; 3.1 %; 1.2 %

CABTREO is a gel of Adapalene / Benzoyl Peroxide / Clindamycin marketed by BAUSCH HEALTH, CANADA INC.. The full Adapalene / Benzoyl Peroxide / Clindamycin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02550423
Brand name
CABTREO
Strength
0.15 %; 3.1 %; 1.2 %
Dosage form
GEL
Route
TOPICAL
Manufacturer
BAUSCH HEALTH, CANADA INC.
Health Canada status
MARKETED
Drug class
Topical combination acne therapy (retinoid + antibiotic + benzoyl peroxide)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.